Revenue
5Y CAGR +17.2%10Y CAGR +9.0%No quarters filed for this figure.
Form 4 transactions by trade date, as filed; latest on file 2026-08-08.
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Bar = where today’s multiple sits in AZN’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
FY25: operating cash flow $14.6B, capex −$2.8B
No quarters filed for this figure.
No quarters filed for this figure.
No quarters filed for this figure.
AstraZeneca PLC American Depositary Shares represent ownership in AstraZeneca PLC, a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. AstraZeneca’s current business spans Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. The company develops and markets treatments used across hospitals, clinics, and specialty care settings, serving patients and healthcare providers in major therapeutic areas with high unmet medical need. Its portfolio is built around branded medicines and regulated drug launches, with ongoing commercial activity across the United States, Europe, and other international markets. AstraZeneca PLC American Depositary Shares provide U.S. investors a way to hold an instrument linked to the company’s underlying shares while participating in the performance of one of the world’s largest research-driven drugmakers.
Cambridge, United Kingdom·96,100 employees·Drug Manufacturers - General·astrazeneca.com·As of Oct 28, 2026
10 of the 193 ETFs ChartRow carries live hold AZN. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| EWU | iShares MSCI United Kingdom ETF | 7.6% |
| VGK | Vanguard FTSE Europe ETF | 1.6% |
| EFA | iShares MSCI EAFE ETF | 1.2% |
| VEA | Vanguard FTSE Developed Markets ETF | 0.9% |
| VEU | Vanguard FTSE All-World ex-US ETF | 0.6% |
| VXUS | Vanguard Total International Stock ETF | 0.6% |
| URTH | iShares MSCI World ETF | 0.3% |
| ACWI | iShares MSCI ACWI ETF | 0.3% |
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +23.75% | +1.14% |
| JNJ | Johnson & Johnson | +14.94% | +0.79% |
| ABBV | AbbVie Inc. | +7.53% | +0.20% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +7.86% | +0.58% |
| MRK | Merck & Co. Inc. | +4.07% | +0.55% |
| NVS | Novartis AG | +12.70% | +0.16% |
| TMO | Thermo Fisher Scientific Inc. | +5.61% | +0.11% |
| AMGN | Amgen Inc. | +12.80% | -0.30% |